Edgar Leonardo Martinez Salazar, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genitalia, Male | 1 | 2019 | 87 | 0.670 |
Why?
|
| Genital Diseases, Male | 1 | 2019 | 83 | 0.650 |
Why?
|
| Genitalia, Female | 1 | 2019 | 146 | 0.630 |
Why?
|
| Genital Diseases, Female | 1 | 2019 | 192 | 0.610 |
Why?
|
| Tendon Entrapment | 1 | 2017 | 6 | 0.610 |
Why?
|
| Hallux | 1 | 2017 | 43 | 0.570 |
Why?
|
| Toes | 1 | 2017 | 209 | 0.550 |
Why?
|
| Tendon Injuries | 2 | 2018 | 328 | 0.450 |
Why?
|
| Ankle Injuries | 1 | 2016 | 338 | 0.400 |
Why?
|
| Plasmodium knowlesi | 1 | 2012 | 23 | 0.400 |
Why?
|
| Malaria, Vivax | 1 | 2014 | 166 | 0.390 |
Why?
|
| Joint Instability | 1 | 2016 | 801 | 0.320 |
Why?
|
| Thrombocytopenia | 1 | 2014 | 1182 | 0.260 |
Why?
|
| Malaria, Falciparum | 1 | 2014 | 1076 | 0.250 |
Why?
|
| Malaria | 1 | 2012 | 1225 | 0.200 |
Why?
|
| Rupture | 2 | 2022 | 443 | 0.180 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2022 | 36415 | 0.160 |
Why?
|
| Elbow Joint | 1 | 2022 | 359 | 0.150 |
Why?
|
| Femoracetabular Impingement | 1 | 2020 | 179 | 0.140 |
Why?
|
| Pectoralis Muscles | 1 | 2018 | 84 | 0.140 |
Why?
|
| Adiposity | 2 | 2018 | 1879 | 0.140 |
Why?
|
| Spondylosis | 1 | 2017 | 84 | 0.140 |
Why?
|
| Fats | 1 | 2016 | 99 | 0.130 |
Why?
|
| Insulin Resistance | 3 | 2018 | 3952 | 0.130 |
Why?
|
| Ligaments, Articular | 1 | 2016 | 302 | 0.110 |
Why?
|
| Pericardium | 1 | 2018 | 674 | 0.110 |
Why?
|
| Colombia | 1 | 2014 | 282 | 0.110 |
Why?
|
| Tongue | 1 | 2016 | 403 | 0.110 |
Why?
|
| Urinary Tract Infections | 1 | 2019 | 801 | 0.110 |
Why?
|
| Quinolines | 1 | 2018 | 764 | 0.110 |
Why?
|
| Respiratory System | 1 | 2016 | 562 | 0.110 |
Why?
|
| Adipose Tissue, Brown | 1 | 2018 | 766 | 0.100 |
Why?
|
| Ankle Joint | 1 | 2016 | 446 | 0.100 |
Why?
|
| Fatty Liver | 1 | 2018 | 789 | 0.100 |
Why?
|
| Arthroscopy | 1 | 2017 | 969 | 0.090 |
Why?
|
| Overweight | 2 | 2018 | 2418 | 0.090 |
Why?
|
| Diagnosis, Differential | 3 | 2019 | 12976 | 0.080 |
Why?
|
| Pituitary Neoplasms | 1 | 2018 | 1322 | 0.080 |
Why?
|
| Ultrasonography | 2 | 2019 | 5969 | 0.070 |
Why?
|
| Glucose Clamp Technique | 2 | 2018 | 262 | 0.070 |
Why?
|
| Adenoma | 1 | 2018 | 2159 | 0.070 |
Why?
|
| Adipose Tissue | 1 | 2018 | 3313 | 0.060 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 3245 | 0.050 |
Why?
|
| Adult | 10 | 2022 | 221119 | 0.050 |
Why?
|
| Humans | 16 | 2022 | 761208 | 0.050 |
Why?
|
| Disease Progression | 1 | 2018 | 13511 | 0.050 |
Why?
|
| Female | 11 | 2022 | 392544 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2018 | 9278 | 0.040 |
Why?
|
| Retrospective Studies | 6 | 2022 | 80674 | 0.040 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2018 | 2024 | 0.040 |
Why?
|
| Inflammation | 1 | 2018 | 10759 | 0.040 |
Why?
|
| Radiopharmaceuticals | 2 | 2018 | 2683 | 0.040 |
Why?
|
| Body Composition | 2 | 2018 | 2427 | 0.040 |
Why?
|
| Male | 10 | 2022 | 360693 | 0.040 |
Why?
|
| Tendons | 1 | 2022 | 558 | 0.040 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2016 | 139 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 15841 | 0.030 |
Why?
|
| Middle Aged | 9 | 2022 | 220853 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2018 | 12341 | 0.030 |
Why?
|
| Femur | 1 | 2020 | 1308 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2014 | 26199 | 0.030 |
Why?
|
| Renin-Angiotensin System | 1 | 2018 | 735 | 0.030 |
Why?
|
| Hip Joint | 1 | 2020 | 1014 | 0.030 |
Why?
|
| Muscular Diseases | 1 | 2018 | 552 | 0.030 |
Why?
|
| Hematoma | 1 | 2018 | 763 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2016 | 933 | 0.030 |
Why?
|
| Infant | 1 | 2014 | 36169 | 0.020 |
Why?
|
| Neck | 1 | 2016 | 734 | 0.020 |
Why?
|
| HIV Infections | 1 | 2018 | 17347 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2014 | 42224 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2019 | 20588 | 0.020 |
Why?
|
| Adolescent | 2 | 2018 | 88298 | 0.020 |
Why?
|
| Neoplasms | 1 | 2018 | 22140 | 0.020 |
Why?
|
| Aged | 5 | 2018 | 169288 | 0.020 |
Why?
|
| Athletic Injuries | 1 | 2018 | 1216 | 0.020 |
Why?
|
| Lipids | 1 | 2018 | 3331 | 0.020 |
Why?
|
| Risk Factors | 3 | 2018 | 74239 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2016 | 2640 | 0.020 |
Why?
|
| Child | 1 | 2014 | 80152 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 11067 | 0.010 |
Why?
|
| Contrast Media | 1 | 2017 | 5311 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2018 | 6392 | 0.010 |
Why?
|
| Insulin | 1 | 2018 | 6588 | 0.010 |
Why?
|
| Sex Factors | 1 | 2018 | 10553 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 12474 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2018 | 11119 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 58952 | 0.010 |
Why?
|
| Liver | 1 | 2018 | 7514 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 14675 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2018 | 8479 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2018 | 64681 | 0.010 |
Why?
|
| Prevalence | 1 | 2018 | 15721 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2018 | 22174 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2016 | 6585 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2016 | 12952 | 0.010 |
Why?
|
| Prognosis | 1 | 2018 | 29687 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2020 | 54435 | 0.010 |
Why?
|
| Obesity | 1 | 2018 | 12939 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 15520 | 0.010 |
Why?
|
| Young Adult | 1 | 2018 | 59221 | 0.010 |
Why?
|